Variant report
Variant | esv3328396 |
---|---|
Chromosome Location | chr21:16907496-16907807 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs73892646 | chr21:16907543-16907544 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs578052632 | chr21:16907554-16907555 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs139051713 | chr21:16907570-16907571 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2823340 | chr21:16907585-16907586 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs80152637 | chr21:16907630-16907631 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs147228660 | chr21:16907646-16907647 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs546532365 | chr21:16907686-16907687 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs180833028 | chr21:16907729-16907730 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs576579272 | chr21:16907730-16907731 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs2823341 | chr21:16907757-16907758 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs541407577 | chr21:16907767-16907768 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs561569169 | chr21:16907789-16907790 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs116518093 | chr21:16907790-16907791 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Cancer | 20164919 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Alzheimer''s disease | 18923514 | CNVD |
Alzheimer''s disease | 20877625 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Alzheimer''s disease | 21956041 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Epilepsy | 20502679 | CNVD |
22q11.2 microdeletion syndrome | 19750312 | CNVD |
Breast cancer | 20409316 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:16906600-16907800 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr21:16906800-16907600 | Enhancers | Primary B cells from peripheral blood | blood |
3 | chr21:16907400-16907600 | Enhancers | Primary B cells from cord blood | blood |
4 | chr21:16907400-16908200 | Enhancers | Primary hematopoietic stem cells | blood |
5 | chr21:16907400-16908200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr21:16907400-16909400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
7 | chr21:16907400-16909400 | Enhancers | Dnd41 | blood |
8 | chr21:16907800-16908200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |